IDORSIA LTD |
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 1,665 CHF | -2,69 % |
|
-7,96 % | -21,24 % |
| 25/07 | Idorsia Ltd comunica los resultados del semestre finalizado el 30 de junio de 2024 | CI |
| 25/07 | Transcript : Idorsia Ltd, H1 2024 Earnings Call, Jul 25, 2024 |
Grupo Idorsia Ltd : Gráfico Relacional
Empresas privadas pertenecientes al mismo grupo que IDORSIA LTD
| Empresa | Director |
|---|---|
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Jean-Paul Clozel |
MarketScreener is also available in this country: United States.
Switch edition
Seguir con la edición actual